The view in contacting you is to r...

The view in contacting you is to raise a inquiry regarding a news item published in the January 2002 issue of ACT. I bewilderment whether you could shed a light on it--or am I just plain wrong!
"CenterWatch reflection Qualifies Risk to Clinical Trial Participants" (Applied Clinical Trials, January 2002 p 19) describes the incident of 13 deaths attributable to contemplation drug effects amongst 122000 controls participating in trials for 130 randomly choiceed NDAs that had received approval since 1987 It finishs that the incidence of death attributable to investigational